Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Raloxifene hydrochloride

EU orphan designation number: EU/3/10/730   
Active ingredient: Raloxifene hydrochloride
Indication: Treatment of hereditary haemorrhagic telangiectasia
Sponsor: Consejo Superior de Investigaciones Cientificas (CSIC)
C/ Serrano 142, E-28006 Madrid, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2010 Orphan designation EMEA/OD/138/09 (2010)3900 of 10/06/2010